Evidence map›Paper›PMID 32300186›Full record

ArticleScientific reports2020

Efficient Drug Screening and Nephrotoxicity Assessment on Co-culture Microfluidic Kidney Chip.

Lei Yin, Guanru Du, Bing Zhang, Hongbo Zhang, Ruixue Yin, Wenjun Zhang, Shih-Mo Yang

Open access · goldAbstract read
In one paragraph

Article in Scientific reports, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 47 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
47citing papers in PubMed, 3 pooled it
5.6field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

47 citing papers in PubMed, 3 syntheses or guidelines pooled it, 109 citations in OpenAlex.

  1. Pooled it
  2. Pooled it
  3. Advances in Engineering Human Tissue Models.Frontiers in bioengineering and biotechnology · 2020
    Pooled it
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Article
  10. Review
  11. Article
  12. Review
  13. Review
  14. Article
  15. Review
  16. Article
  17. Review
  18. Review
  19. Review
  20. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 3 institutions in 2 countries.

Lei YinSchool of Mechanical and Power Engineering, East China University of Science and Technology, Shanghai, P.R. China.
Guanru DuSchool of Mechanical and Power Engineering, East China University of Science and Technology, Shanghai, P.R. China.
Bing ZhangBiomedical Science and Technology Research Center, School of Mechatronic Engineering and Automation, Shanghai University, Shanghai, P.R. China.ORCID http://orcid.org/0000-0001-5650-2518
Hongbo ZhangSchool of Mechanical and Power Engineering, East China University of Science and Technology, Shanghai, P.R. China.
Ruixue YinBiomedical Science and Technology Research Center, School of Mechatronic Engineering and Automation, Shanghai University, Shanghai, P.R. China.
Wenjun ZhangDivision of Biomedical Engineering, University of Saskatchewan, Saskatoon, Canada.
Shih-Mo YangSchool of Mechanical and Power Engineering, East China University of Science and Technology, Shanghai, P.R. China. smyang@shu.edu.cn.
East China University of Science and Technology · CNShanghai University · CNUniversity of Saskatchewan · CA

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

The function and susceptibility of various drugs are tested with renal proximal tubular epithelial cells; yet, replicating the morphology and kidneys function using the currently available in vitro models remains difficult. To overcome this difficulty, in the study presented in this paper, a device and a three-layer microfluidic chip were developed, which provides a simulated environment for kidney organs. This device includes two parts: (1) microfluidic drug concentration gradient generator and (2) a flow-temperature controlled platform for culturing of kidney cells. In chip study, renal proximal tubular epithelial cells (RPTECs) and peritubular capillary endothelial cells (PCECs) were screened with the drugs to assess the drug-induced nephrotoxicity. Unlike cells cultured in petri dishes, cells cultured in the microfluidic device exhibited higher performance in terms of both cell growth and drug nephrotoxicity evaluation. It is worth mentioning that a significant decrease in cisplatin-induced nephrotoxicity was found because of the intervention of cimetidine in the microfluidic device. In conclusion, the different in the cell performance between the microfluidic device and the petri dishes demonstrates the physiological relevance of the nephrotoxicity screening technology along with the microfluidic device developed in this study. Furthermore, this technology can also facilitate the development of reliable kidney drugs and serve as a useful and efficient test-bed for further investigation of the drug nephrotoxicity evaluation.

Indexed as

Drug Evaluation, PreclinicalMicrofluidicsCell SurvivalCisplatinCoculture TechniquesEndothelial CellsEpithelial CellsFluorescenceHumansKidneyMembranesPermeabilityTemperatureCisplatin

Identifiers

PMID32300186
PMCPMC7162892
OpenAlexW3017361865

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.